- Home
- CHRS vs DTSQ Comparison
CHRS vs DTSQ Comparison
Compare CHRS & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- DTSQ
- Stock Information
- Founded
- CHRS 2010
- DTSQ 2022
- Country
- CHRS United States
- DTSQ United States
- Employees
- CHRS N/A
- DTSQ N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- DTSQ
- Sector
- CHRS Health Care
- DTSQ
- Exchange
- CHRS Nasdaq
- DTSQ NYSE
- Market Cap
- CHRS 100.9M
- DTSQ 89.0M
- IPO Year
- CHRS 2014
- DTSQ 2024
- Fundamental
- Price
- CHRS $1.09
- DTSQ $10.04
- Analyst Decision
- CHRS Strong Buy
- DTSQ
- Analyst Count
- CHRS 4
- DTSQ 0
- Target Price
- CHRS $6.13
- DTSQ N/A
- AVG Volume (30 Days)
- CHRS 3.4M
- DTSQ 2.4K
- Earning Date
- CHRS 11-06-2024
- DTSQ 01-01-0001
- Dividend Yield
- CHRS N/A
- DTSQ N/A
- EPS Growth
- CHRS N/A
- DTSQ N/A
- EPS
- CHRS N/A
- DTSQ 0.17
- Revenue
- CHRS $304,340,000.00
- DTSQ N/A
- Revenue This Year
- CHRS $3.33
- DTSQ N/A
- Revenue Next Year
- CHRS $16.77
- DTSQ N/A
- P/E Ratio
- CHRS N/A
- DTSQ $60.36
- Revenue Growth
- CHRS 44.19
- DTSQ N/A
- 52 Week Low
- CHRS $0.66
- DTSQ $9.96
- 52 Week High
- CHRS $3.70
- DTSQ $10.06
- Technical
- Relative Strength Index (RSI)
- CHRS 68.04
- DTSQ N/A
- Support Level
- CHRS $0.70
- DTSQ N/A
- Resistance Level
- CHRS $1.17
- DTSQ N/A
- Average True Range (ATR)
- CHRS 0.11
- DTSQ 0.00
- MACD
- CHRS 0.05
- DTSQ 0.00
- Stochastic Oscillator
- CHRS 84.31
- DTSQ 0.00
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.